![](/img/cover-not-exists.png)
Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan
Tanaka, Yoshiya, Mimori, Tsuneyo, Yamanaka, Hisashi, Nakajima, Ryo, Morita, Kazuo, Kimura, Junko, Takeuchi, TsutomuLanguage:
english
Journal:
Modern Rheumatology
DOI:
10.1080/14397595.2018.1500979
Date:
July, 2018
File:
PDF, 1.10 MB
english, 2018